Daily Stock Analysis, AKRX, Akorn Inc, priceseries

Akorn Inc. Daily Stock Analysis
Stock Information
Open
4.80
Close
4.73
High
4.83
Low
4.66
Previous Close
4.78
Daily Price Gain
-0.05
YTD High
4.86
YTD High Date
Jun 19, 2019
YTD Low
2.64
YTD Low Date
May 2, 2019
YTD Price Change
1.25
YTD Gain
35.92%
52 Week High
19.65
52 Week High Date
Aug 8, 2018
52 Week Low
2.64
52 Week Low Date
May 2, 2019
52 Week Price Change
-10.92
52 Week Gain
-69.78%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 5. 2017
23.96
May 17. 2017
33.17
29 Trading Days
38.42%
Link
LONG
Jun 5. 2018
14.20
Jul 12. 2018
17.10
26 Trading Days
20.42%
Link
LONG
May 6. 2019
3.03
May 24. 2019
4.05
14 Trading Days
33.62%
Link
Company Information
Stock Symbol
AKRX
Exchange
NasdaqGS
Company URL
http://www.akorn.com
Company Phone
847-279-6100
CEO
Rajat Rai
Headquarters
Illinois
Business Address
1925 W. FIELD COURT, SUITE 300, LAKE FOREST, IL 60045
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0000003116
About

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Description

Akorn, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets specialized generic and branded pharmaceuticals, over-the-counter (OTC) drug products, and animal health products in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. This segment's primary products include Atropine Sulfate Ophthalmic Solution; Clobetasol Propionate Cream And Ointment; Ephedrine Sulfate Injection; Lidocaine Ointment; Methylene Blue Injection; Myorisan soft gelatin capsules; Nembutal sodium solution; Phenylephrine Hydrochloride Ophthalmic Solution; and Zioptan tafluprost ophthalmic solution. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products, including Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.